A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

Clinical trial NCT04072458 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04072458
Sponsor: Bio-Path Holdings, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mantle Cell Lymphoma Peripheral T-cell Lymphoma (PTCL)Cutaneous T-cell Lymphoma (CTCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Follicular Lymphoma Marginal Zone Lymphoma Hodgkin Lymphoma Waldenstrom Macroglobulinemia DLBCL

Start date: 2020-11-05
Primary completion: 2025-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.